Ibopamine
1985; Wiley; Volume: 3; Issue: 1 Linguagem: Tagalog
10.1111/j.1527-3466.1985.tb00478.x
ISSN1527-3466
AutoresC Casagrande, P Ghirardi, G Marchetti,
Tópico(s)Neurological and metabolic disorders
ResumoCardiovascular Drug ReviewsVolume 3, Issue 1 p. 173-196 Free to Read Ibopamine Cesare Casagrande, Cesare Casagrande Simes Research Laboratories and Medical Department, 20161 Milan, ItalySearch for more papers by this authorPaolo Ghirardi, Paolo Ghirardi Simes Research Laboratories and Medical Department, 20161 Milan, ItalySearch for more papers by this authorGermano Marchetti, Germano Marchetti Simes Research Laboratories and Medical Department, 20161 Milan, ItalySearch for more papers by this author Cesare Casagrande, Cesare Casagrande Simes Research Laboratories and Medical Department, 20161 Milan, ItalySearch for more papers by this authorPaolo Ghirardi, Paolo Ghirardi Simes Research Laboratories and Medical Department, 20161 Milan, ItalySearch for more papers by this authorGermano Marchetti, Germano Marchetti Simes Research Laboratories and Medical Department, 20161 Milan, ItalySearch for more papers by this author First published: March 1985 https://doi.org/10.1111/j.1527-3466.1985.tb00478.xCitations: 4AboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat REFERENCES 1 Akpaffiong, M. J., Redfern, P. H., and Woodward, B. (1980): Factors affecting the release and excretion of dopamine in the rat. J. Pharm. Pharmacol., 32: 839–443. 10.1111/j.2042-7158.1980.tb13087.x CASPubMedWeb of Science®Google Scholar 2 Baggio, G., Ferrari, F., Guarini, S., Sandrini, M., and Ferrari, W. (1981): Diuretic effect of dopaminomimetic agents. In: Apomorphine and Other Dopaminomimetics. Basic Pharmacology. Vol. I, edited by G. L. Gessa and G. U. Cossini, pp. 285–295. Raven Press, New York . Google Scholar 3 Boyce, M., Dalton, N., Goodwin, B., Walker, P., Weg, M., and Sandler, M. (1984): Disposition of equimolar dose of epinine and ibopamine, the di-isobutyryl ester of epinine in healthy subjects. Br. J. Pharmacol., 83: P37. Google Scholar 4 Brusoni, B., Gasparini, M., Gronda, E., Inglese, E., and Mangiavacchi, M. (1984): Effetti acuti e cronici della ibopamina (IB). Studio con cineventricolografia radioisotopica (CVGR). Congr. Naz. Cardiol. (A.N.M.C.O.), 15th, Firenze. Google Scholar 5 Cadel, A., Brusoni, B., Fanciulli, R., Pria, B., and Conversano, S. (1982): Ibopamine, digoxin and placebo in ischemic heart failure. Symposium on Dopamine Receptor Agonists, Stockholm . Poster communications, P4. Google Scholar 6 Caldara, R., Masci, E., Barbieri, C., Cambielli, M., Ferrari, C., and Tittobello, A. (1983): Dopaminergic control of gastric acid and gastrin secretion in man: Lack of effects after acute oral administration of ibopamine, an analogue of dopamine. Br. J. Clin. Pharmacol., 16: 112–114. 10.1111/j.1365-2125.1983.tb02154.x CASPubMedWeb of Science®Google Scholar 7 Casagrande, C., Castelnovo, P., Cerri, O., Ferrini, R., Merlo, L., Miragoli, G., Paro, M., Pataccini, F., and Santangelo, F. (1984): Ibopamine: Investigation of metabolism and pharmacokinetics in relationship to pharmacodynamics. Int. Symp. Medicinal Chem., 8th, Uppsala , P 72. Google Scholar 8 Casagrande, C., Ferrari, G., Ferrini, R., Miragoli, G., Merlo, L., Mussini, E., Parenti, M., and Ghirardi, P. (1980): Ibopamine, an orally active dopamine-like drug. Int. Symp. Medicinal Chem., 7th, Torremolinos . Google Scholar 9 Chapman, B. J., Lush, S. E., and Munday, K. A. (1980): The actions of dopamine on urine flow and sodium excretion in the rat. J. Physiol., 302: 7P–8P. CASGoogle Scholar 10 Ciampani, N., Amici, R., Pigini, G., Ruga, O., Silenzi, C., and Purcaro, A. (1984): Confronto tra gli effetti emodinamici della dopamina e della ibopamina. Congr. Naz. Cardiol. (A.N.M.C.O.), 15th, Firenze. Google Scholar 11 Ciampani, N., Breccia Fratadocchi, G., Capestro, F., Massacci, C., Mocchegiani, R., and Purcaro, A. (1984): Valutazione elettrofisiologica della ibopamina. Congr. Naz. Cardiol. (A.N.M.C.O.), 15th, Firenze. Google Scholar 12 Cicchetti, F., Bruni, G. C., Loreti, P., Pamparana, F., Bauer, R., and Borghi, G. M. (1980): Behaviour of diuresis, blood arterial pressure and heart rate after SB 7505 (ibopamine hydrochloride) administration. Curr. Ther. Res., 27: 741–747. Web of Science®Google Scholar 13 Col, J., Mievis, E., and Reynaert, M. (1983): Ibopamine in very severe congestive heart failure: Pilot haemodynamic invasive assessment. Eur. J. Clin. Pharmacol., 24: 297–300. 10.1007/BF00610044 CASPubMedWeb of Science®Google Scholar 14 Dei Cas, L., Barilli, A. C., Metra, M., Fracalossi, C., Lomanto, B., Santambrogio, S., Pinca, L., Longhini, C., Cavicchi, E., Maggi, G. C., Montani, E., Lattuada, S., Libretti, A., Gavazzi, A., Mussini, A., Specchia, S., Ghirardi, P, Bianco, L., and Visioli, O. (1984): Indagine clinica multicentrica sull'efficacia terapeutica dell'ibopamina in pazienti con scompenso cardiaco grave. G. Ital. Cardiol., in press. Google Scholar 15 Dei Cas, L., Bolognesi, R., Cucchini, F., Fappani, A., Riva, S., and Visioli, O. (1983): Hemo-dynamic effects of ibopamine in patients with idiopathic congestive cardiomyopathy. J Cardiovasc. Pharmacol., 5: 249–253. 10.1097/00005344-198303000-00014 CASPubMedWeb of Science®Google Scholar 16 Dei Cas, L., Fappani, A., Manca, C., Metra, M., Riva, S., and Petroboni, V (1983): Uso combinato di nitroprussiato ed ibopamina in soggetti con scompenso cardiaco: Studio emodinamico. Congr. Soc. Ital. Cardiol., 64th, Torino . Google Scholar 17 Dei Cas, L., Longhini, C., Lattuada, S., Gavazzi, A., Mussini, A., Maggi, G. C., Fracalossi, C., and Santambrogio, S.: Indagine policentrica sull'efficacia clinica dell'ibopamina somministrata cronicamente. Boll. Soc. Ital. Cardiol., in press. Google Scholar 18 Dei Cas, L., Manca, C., Bernardini, B., Vasini, G., and Visioli, O. (1982): Noninvasive evaluation of the effects of oral ibopamine (SB 7505) on cardiac and renal function in patients with congestive heart failure. J. Cardiovasc. Pharmacol., 4: 436–400. 10.1097/00005344-198205000-00014 CASPubMedWeb of Science®Google Scholar 19 Dei Cas, L., Manca, C., Vasini, G., Mansour, M., Bernardini, B., and Visioli, O. (1980): Noninvasive evaluation of left ventricular function through systolic time intervals following oral administration of SB 7505 in man. Arzneimittelforsch., 30: 498–500. CASPubMedWeb of Science®Google Scholar 20 Dei Cas, L., Visioli, O., Casagrande, C., and Ghirardi P. (1980): Oral inotropic activity of the dopamine derivative (SB 7505) in healthy (HS) and congestive heart failure subjects (CHFS). World Conf. Clin. Pharmacol. Therapeutics, London . Google Scholar 21 Dore, L., Sannia, L., Ibba, G. V., Castellaccio, M., Carta, G., and Frau, G. (1984): Comparazione degli effetti acuti della ibopamina e della dopamina nello scompenso cardiaco congestizio cronico (SCCC). Studio ecocardiografico. Congr. Naz. Cardiol. (A.N.M.C.O.), 15th, Firenze. Google Scholar 22 Ferrari, C., Barbieri, C., Caldara, R., Rampini, P., Paracchi, A., Boghen, M., and Rauhe, W. G. (1983): Effects of ibopamine on serum prolactin and growth hormone levels in hyperprolactinemic and acromegalic subjects. Clin. Pharmacol. Ther., 34: 74–78. 10.1038/clpt.1983.132 CASPubMedWeb of Science®Google Scholar 23 Ferrini, R., and Miragoli, G.: Activity of ibopamine on some isolated organs. Arzneim.-Forsch., in press. Google Scholar 24 Ferrini, R., and Miragoli, G. Effect of ibopamine on diuresis and arterial blood pressure in anaesthetized rats, and its interactions with dopaminergic and α- and β-adrenergic antagonists. Arzneim.-Forsch., in press. Google Scholar 25 Ferrini, R., Miragoli, G., Sala, R., and Reggiani, A.: Activity of ibopamine on central nervous system in mice and rats. Arzneim.-Forsch. (in press). Google Scholar 26 Gavazzi, A., Bramucci E., Mussini, A., Lanzarini, L., de Servi, S., Specchia, G., and Ghirardi, P. (1983): Studio emodinamico di un derivato dopaminergico (ibopamina) nello scompenso cardiaco congestizio: risultati preliminari. Congr. Naz. Cardiol. (A.N.M.C.O.), 14th, Bologna . Google Scholar 27 Ghirardi, P., Brusoni, B., Mangiavacchi, M., Cucchini, F., and Dei Cas, L. (1983): Ibopamine: an invasive haemodynamic evaluation in severe congestive heart failure (CHF). Acta Pharmac. Suecica, Suppl. 2: 210–212. Google Scholar 28 Gilman, G. A., Goodman, L. S., Gilman, A. (1980): In: The Pharmacological Basis of Therapeutics, 6th Ed., pages 154, 169, MacMillan Publ., New York . Google Scholar 29 Gilman, G. A., Goodman, L. S., Gilman, A. (1980): In: The Pharmacological Basis of Therapeutics, 6th Ed., page 146, MacMillan Puhl., New York . Google Scholar 30 Goldberg, L. I. (1968): Use of sympathomimetic amines in heart failure. Amer. J. Cardiol., 22: 177–182. 10.1016/0002-9149(68)90223-3 CASPubMedWeb of Science®Google Scholar 31 Goldberg, L. I. (1972): Cardiovascular and renal actions of dopamine: potential clinical applications. Pharmacol. Rev., 24: 1–29. CASPubMedWeb of Science®Google Scholar 32 Goldberg, L. I. (1983): Clinical actions of dopamine and oral dopamine preparations. World Conf. Clin. Pharmacol. Therapeutics, 2nd, Washington . Google Scholar 33 Goldberg, L. I., and Kohli, J. D. (1981): Agonist and antagonists of peripheral pre- and post- synaptic dopamine receptors: clinical implications. In: Apomorphine and other dopaminomimetics, Vol. I, Basic Pharmacology, edited by G. L. Gessa and G. U. Corsini, pp. 273–284. Raven Press, New York . Google Scholar 34 Goldberg, L. I., McDonald, R. H., Jr., and Zimmermann, A. M. (1963): Sodium diuresis produced by dopamine in patients with congestive heart failure. New England J. Med., 269: 1060–1064. 10.1056/NEJM196311142692003 CASPubMedWeb of Science®Google Scholar 35 Goldberg, L. I., Volkman, P. H., and Kohli, J. D. (1978): A comparison of the vascular dopamine receptor with other dopamine receptors. Ann. Rev. Pharmacol. Toxicol., 8: 57–79. 10.1146/annurev.pa.18.040178.000421 CASWeb of Science®Google Scholar 36 Gristwood, R. W., and Owen, D. A. A. (1983): The effects of ibopamine, an orally active dopamine analogue, on the guinea-pig isolated working heart. Brit. J. Pharmacol., 78 (suppl.): 30P. Google Scholar 37 Guagliumi, G., Gattone, M., and Travazzi, L. (1984): Effetti emodinamici a riposo e durante sforzo della somministrazione acuta di ibopamina in pazienti con infarto miocardico recente e insufficienza cardiaca latente. Congr. Naz. Cardiol. (A.N.M.C.O.), 15th, Firenze . Google Scholar 38 Harvey, C. A., and Owen, D. A. A. (1983): Haemodynamic responses to ibopamine, an orally active dopamine analogue, in anaesthetized cats. Brit. J. Pharmacol., 78 (suppl.): 127P. Google Scholar 39 Harvey, J. N., Worth, D. P., Brown, J., and Lee, M. R. (1984): Lack of effect of ibopamine, a dopamine pro-drug, on renal function in normal subjects. Brit. J. Clin. Pharmac., 17: 671–677. 10.1111/j.1365-2125.1984.tb02402.x CASPubMedWeb of Science®Google Scholar 40 Hwang, B. Y.-H., Kuo, G. Y., and Lynn, R. K. (1984): Ibopamine metabolites in rat and dog urine. IUPHAR Int. Congr. Pharmacol., 9th, London , 523P. Google Scholar 41 Joseph, G., Flagiello, J., Jr.: Tissue distribution and pharmacokinetics of orally administered 14Cibopamine in the rat. Smith Kline & French Labs., Philadelphia (unpublished report). Google Scholar 42 Kawahara, K., and Inui, J. (1984): Analysis of positive inotropic effects of ibopamine in the blood-perfused canine papillary muscle. Gen. Meeting Jap. Pharmacol. Soc., 57th, Kyoto . Google Scholar 43 Ladelli, L., Pezzano, A., Sala, G., Mangiavacchi, M., Cadel, A., and Brusoni, B. (1983): Studio ecocardiografico e poligrafico degli effetti acuti della ibopamina sulla performance cardiaca. G. Ital. Cardiol., 13/II: 239–248. Google Scholar 44 Ladelli, L., Sala, G., Pezzano, A., Mangiavacchi, M., and Brusoni B. (1983): Doulbe-blind noninvasive study (echocardiographic and polygraphic) of ibopamine in healthy subjects and patients with congestive heart failure. Acta Pharm. Suecica, 2 (suppl.): 224–227. Google Scholar 45 Langer, S. Z. (1974): Presynaptic regulation of catecholamine release. Biochem. Pharmacol., 23: 1793–1800. 10.1016/0006-2952(74)90187-7 CASPubMedWeb of Science®Google Scholar 46 Langer, S. Z., Starke, K., and Dubocovich, M. D. (1979): In: Presynaptic Receptors, Advances in the Biosciences. Pergamon Press, Oxford . Google Scholar 47 Lodola, E., et al. (1984): Ibopamine, an orally active dopamine-like drug: metabolism and pharmacokinetics in man. Paper in preparation. Google Scholar 48 Lombardi, G., Tommaselli, A., Fariello, C., Quattrone, A., and Annunziato, L. (1983): Effect of the orally absorbed dopamine analogue N-methyldopamine diisobutyric ester on plasma prolactin levels. Eur. J. Clin. Pharmacol., 25: 131–133. 10.1007/BF00544029 CASPubMedWeb of Science®Google Scholar 49 Longhini, C., Musacci, G. F., Ansani, L., Toselli, T., Artioli, M., Bianco, L., and Ghirardi, P. (1983): Effect of ibopamine on peripheral haemodynamic. Eur. J. Clin. Pharmacol., 24: 585–589. 10.1007/BF00542205 CASPubMedWeb of Science®Google Scholar 50 Longhini, C., Taddeo, U., Musacci, G. F., Artioli, M., and Ansani, L. (1983): L'aggregabilità piastrinica dopo somministrazione di ibopamina nell'uomo sano. Prog. med., 39: 275–277. Google Scholar 51 Luppi, G., Cappello, C., Pedrazzini, F., and Mattioli, G. (1984): Effetti emodinamici dell'ibopamina nell'insufficienza cardiaca cronica. Giornale di Clinica e Fisiopatologia Cardiovascolare, II: 51–64. Google Scholar 52 Marchetti, G., Longo, T., Merlo, L., and Noseda, V. (1973): Effect of dopamine on cardiogenic and endotoxin experimental shock. Eur. Surg. Res., 5: 175–185. 10.1159/000127656 CASPubMedWeb of Science®Google Scholar 53 Marchetti, G., and Merlo, L.: Effects of ibopamine on acute cardiac failure following experimental coronary occlusion in dogs. Arzneim.-Forsch. (in press).. Google Scholar 54 McDonald, R. H. Jr., Goldberg, L. I., McNay, J. L., and Tuttle, E. P., Jr. (1964): Effects of dopamine in man: augmentation of sodium excretion, glomerular filtration rate, and renal plasma flow. J. Clin. Invet., 43: 1116–1124. 10.1172/JCI104996 CASPubMedWeb of Science®Google Scholar 55 Melloni, G. F., Catenazzo, G., Scarazzati, G., and Bianco, L. (1983): Ibopamine: an orally active dopaminergic agent. Acta Pharmac. Suecica, 2 (suppl.): 230–233. Google Scholar 56 Melloni, G. F., Melloni, R., Minoja, G. M., Scarazzati, G., Bruni, G. C., Loreti, P., and Bauer, R. (1981): Clinical tolerability of ibopamine hydrochloride (SB 7505). Eur. J. Clin. Pharmacol., 19: 409–411. 10.1007/BF00548583 CASPubMedWeb of Science®Google Scholar 57 Melloni, G. F., Minoja, G. M., Lureti, G. F., Bagliani, M., Brusoni, B., Pamparana, F., and Ghirardi, P. (1979): Clinical dot trial on SB 7505. Curr. Ther. Res., 26: 466–470. Web of Science®Google Scholar 58 Melloni, G. F., Minoja, G. M., Lureti, G. F., Bruni, G. C., Loreti, P., Pamparana, F., Brusoni, B., and Ghirardi, P. (1979): Effects of SB 7505 on blood pressure, heart rate and diuresis in man. Curr. Ther. Res., 25: 406–414. Web of Science®Google Scholar 59 Melloni, G. F., Minoja, G. M., Melloni, R., Piatto, E., Scarazzati, G., Bauer, R., and Ghirardi, P. (1981): Effectiveness of ibopamine in the management of ascitic liver cirrhosis - A controlled study versus placebo and frusemide. Brit. J. Clin. Pharmacol., 12: 813–818. 10.1111/j.1365-2125.1981.tb01312.x CASPubMedWeb of Science®Google Scholar 60 Melloni, G. F., Minoja, G. M., Scarazzati, G., Bauer, R., Brusoni, B., and Ghirardi, P. (1981): Renal effects of SB 7505: a double-blind study. Eur. J. Clin. Pharmacol., 19: 177–180. 10.1007/BF00561945 PubMedWeb of Science®Google Scholar 61 Mengeot, Ph., Piette, F., and Mirgaux, M. (1981): Double-blind haemodynamic study of a new dopamine derivative (diisobutyric ester of N-methyl-dopamine) orally active in chronic congestive heart failure. G. Ital. Cardiol., 11: 1738–1742. CASPubMedGoogle Scholar 62 Merlo, L., Brusoni, B., Mussini, E., and Ghirardi, P. (1981): Attività della ibopamina su alterazioni della emodinamica del distretto renale indotte sperimentalmente nel cane anestetizzato. Boll. Soc. Ital. Cardiol., 26: 1569–1575. CASPubMedGoogle Scholar 63 Merlo, L., Brusoni, B., Mussini, E., and Ghirardi, P. (1983): Activity of di-isobutyric ester of N-methyl-dopamine (ibopamine) on regional haemodynamics of anaesthetized dogs. Acra Pharm. Suecica, 2 (suppl.): 234–236. Google Scholar 64 Merlo, L., Ghirardi, P., Brusoni, B., Mussini, E., and Marchetti, G.: Effects of ibopamine on systemic, pulmonary and regional haemodynamics. An experimental investigation on anaesthetized dogs. Arzneim.-Forsch. (in press). Google Scholar 65 Miragoli, G., and Ferrini, R. : Effect of ibopamine on diuresis in concious rats in normal and experimentally altered conditions. Arzneim.-Forsch. (in press).. Google Scholar 66 Montani, E., Triulzi, M. O., and Maggi, G. C. (1982): Effect of ibopamine on heart rate and spontaneous premature ventricular beats in patients with angina pectoris. Eur. J. Clin. Pharmacol., 21: 369–371. 10.1007/BF00542320 CASPubMedWeb of Science®Google Scholar 67 Nicaise, J., and Vryens, R. (1981): Etude controlée de l'activite de l'ibopamine (SB 7505) chez des patients ages présentant une stase pulmonaire et des oedèmes aus membres inférieurs. Acta Therap., 7: 67–79. Google Scholar 68 Nicaise, J., and Vryens, R. (1982): Ibopamine in geriatric patients with cardiac and chronic renal failure: a clinical study II Farmaco, Ed. Pratica, 37: 65–70. CASPubMedGoogle Scholar 69 Pendleton, R. G., and Sherman, S. S. (1976): Studies concerning dopamine diuresis in the rat. Arch. int. Pharmacodyn., 222: 94–102. CASPubMedWeb of Science®Google Scholar 70 Pocchiari, F., Pataccini, R., Castelnovo, P., Longo, A., and Casagrande, C. : Ibopamine , an orally active dopamine-like drug: metabolism and pharmacokinetic in dogs.Arzneim.-Forsch. (in press).. Google Scholar 71 Pocchiari, F., Pataccini, R., Castelnovo, P., Longo, A., and Casagrande, C. : Ibopamine , an orally active dopamine-like drug: metabolism and pharmacokinetic in dogs. Arzneim.-Forsch. (in press).. Google Scholar 72 Randolph, W. C., Swagzdis, J. E., Joseph, G. L., and Gifford, R. (1983): Circulating levels of epinine & epinine conjugates in rat, dog & man following oral administration of ibopamine. Pharmacologist, 25: 117. Google Scholar 73 Reffo, G. C., Turrin, M., Gabellini, A., and Forattini, C. (1984): Hemodynamic evaluation of ibopamine in severe congestive heart failure. Eur. J. Clin. Pharmacol., 26: 19–22. 10.1007/BF00546702 CASPubMedWeb of Science®Google Scholar 74 Ren, J.-H., Leithe, M. E., Huss, P., Unverferth, D. V., and Leier, C. V. (1983): The effects of ibopamine on cardiovascular and renal function in normal human subjects. Curr. Ther. Res., 34: 667–675. CASWeb of Science®Google Scholar 75 Ren, J.-H., Unverferth, D. V., and Leier, C. V.: The dopamine congener, ibopamine, in congestive heart failure. J Cardiovasc. Phurmacol. (in press). Google Scholar 76 Rossen, J. D., Goldberg, L. I., and Rajfer, S. I.: Long-term therapy with oral ibopamine in heart failure. (In preparation.). Google Scholar 77 Salerno, F., Morganti, A., Graziani, G., Incerti, P. L., Bolla, G., Lorenzano, E., and Ghirardi, P. (1984): Ibopamine, a dopamine derivative, acutely enhances sodium excretion by glomerular and tubular mechanisms in cirrhotic patients. Eur. Soc. Clin. Invest. Ann. Sci. Meeting, Milan.. Google Scholar 78 Sannia, L., Ibba, G. V., Castellaccio, M., Frau, G., and Dore, L. (1984): Comparazione degli effetti acuti dell'ibopamina e della dopamina nello scompenso cardiaco congestizio cronico (SCCC). Studio emodinamico. Congr. Naz. Cardiol. (A.N.M.C.O.), 15th, Firenze. Google Scholar 79 Scarazzati, E., Catenazzo, G., Melloni, G. F., Ghirardi, P., and Bianco, L. (1983): Valutazione preliminare dell'effetto della ibopamina sulla secrezione di prolattina. Boll. Soc. Ital. Biol. Sperim., 59: 1631–1635. CASPubMedGoogle Scholar 80 Shiroyama, N., Itoh, H., Nitta, M., Miyahara, Y., Kirigaya, H., Taniguchi, K., and Takeuchi, J. (1983): Effect of an oral dopamine derivative, ibopamine, on hemodynamics in patients with heart failure. Meeting Jap. Soc. Clin. Pharmacol. Therapeutics, 4th, Kyoto . Google Scholar 81 Sophasan, S., Sanposn, W, Kraisawekwisai, S., and Chatsudthipong, V. (1981): The effects of dopamine on kidney function of rat. Arch. Int. Pharmacodyn., 252: 219–228. CASPubMedWeb of Science®Google Scholar 82 Stefoni, S., Coli, L., Mosconi, G., and Prandini, R. (1981): Ibopamine (SB 7505) in normal subjects and in chronic renal failure: a preliminary report. Brit. J. Clin. Pharmac., 1: 69–72. 10.1111/j.1365-2125.1981.tb01104.x Google Scholar 83 Stefoni, S., Docci, D., Vangelista, A., Mosconi, G., Coli, L., and Prandini, R. (1982): Longterm treatment of chronic renal insufficiency with ibopamine (SB 7505), a new orally active dopamine-related drug. Clinical Nephrology, 18: 168–173. CASPubMedWeb of Science®Google Scholar 84 Swagzdis, J. E., Ferullo, C. R., Hutchings, G., and Joseph, G. (1984): 14C-ibopamine single dose pharmacokinetics in the dog. Smith Kline & French Labs. (unpublished report). Google Scholar 85 Tiggermann, R., Klinn, H. D., Schober, A., Suermann, T., and Clowdus, B.: A placebo-controlled multicenter study on the effect of treatment with ibopamine compared with that of digoxin in patients with chronic congestive heart failure. (In preparation.). Google Scholar 86 Tsuru, M., Ohashi, K., Fujimura, A., and Ebihara, A. (1983): Clinical pharmacology of ibopamine; pharmacokinetics and pharmacology in healthy volunteers. West-South Ann. Meeting Jap. Pharmacol. Soc., 36th, Fukuoka . Google Scholar Citing Literature Volume3, Issue1March 1985Pages 173-196 ReferencesRelatedInformation
Referência(s)